Role of matrix metalloproteinases in diabetic foot ulcers: Potential therapeutic targets

Role of matrix metalloproteinases in diabetic foot ulcers: Potential therapeutic targets

Diabetic foot ulcers (DFUs) are pathological states of tissue destruction of the foot or lower extremity in diabetic patients and are one of the serious chronic complications of diabetes mellitus. Matrix metalloproteinases (MMPs) serve crucial roles in both pathogenesis and wound healing. The primar...

Full description

Bibliographic Details
Main Authors:	Kang Fu, Xueyao Zheng, Yuhan Chen, Liuying Wu, Zhiming Yang, Xu Chen, Wei Song
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Pharmacology
Subjects:	diabetic foot ulcers matrix metalloproteinases tissue inhibitors of metalloproteinases MMP inhibitors wound healing
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1050630/full

Similar Items

Targeting MMP-9 in Diabetic Foot Ulcers
by: Jeffrey I. Jones, et al.
Published: (2019-05-01)

Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects
by: Kamil Brzóska, et al.
Published: (2014-09-01)

The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
by: Gregg B. Fields
Published: (2019-08-01)

Matrix metalloproteinases and their inhibitors
by: O. S. Grigorkevich, et al.
Published: (2019-02-01)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)

Association of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels with diabetic foot ulcer in Egyptians with type 2 diabetes mellitus
by: Ghada H Sayed, et al.
Published: (2018-01-01)

Time-dependent matrix metalloproteinases and tissue inhibitor of metalloproteinases expression change in fusarium solani keratitis
by: Qian Li, et al.
Published: (2016-04-01)

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
by: Natheer Hashim Al-Rawi, et al.
Published: (2014-01-01)

Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Ratio: A Biomarker of Bone Resorption in Geriatric Osteoporosis?
by: Bahar Bektan Kanat, et al.
Published: (2023-06-01)

Matrix metalloproteinases, inhibitor of metalloproteinases mRNA and protein expression in laryngeal squamous cell carcinoma
by: Weronika Lucas Grzelczyk, et al.
Published: (2019-04-01)

In silico Study of Some Natural Anthraquinones on Matrix Metalloproteinase Inhibition
by: Amir Taherkhani, et al.
Published: (2021-10-01)

Perioceutics: Matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal disease
by: Esther Nalini Honibald, et al.
Published: (2012-01-01)

Clinical implications of urine matrix metalloproteinases assay in patients with chronic glomerulonephritis
by: Ol'ga Aleksandrovna Li, et al.
Published: (2009-08-01)

COMPARATIVE EVALUATION OF SKIN SUTURE IN RATS WITH POLYGLYCAPRONE 25 AND NYLON
by: RAFAEL SALEME ALVES, et al.
Published: (2023-07-01)

Matrix metalloproteinases as therapeutic targets in breast cancer
by: Mi Jeong Kwon, et al.
Published: (2023-01-01)

Activation and Inhibition of Human Matrix Metalloproteinase-9 (MMP9) by HOCl, Myeloperoxidase and Chloramines
by: Yihe Wang, et al.
Published: (2022-08-01)

Significance of matrix metalloproteinases and their ihhibitors in normal subjects, solid and blood cancer patients
by: Nadezhda Vladimirovna Gaydamaka, et al.
Published: (2009-07-01)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Echinoderms: Structure and Possible Functions
by: Igor Yu. Dolmatov, et al.
Published: (2021-09-01)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017-01-01)

The Effect of Candida Albicans Systemic Infection on Matrix Metalloproteinases in Breast Cancer Bearing Balb/c Mice
by: Fatemeh Hajari Taheri, et al.
Published: (2013-03-01)

The predictive function of rates of matrix metalloproteinases/inhibitors system when assessing reparative changes in the lung tissue in those with infiltrate pulmonary tuberculosis
by: D. S. Esmedlyaevа, et al.
Published: (2018-10-01)

Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis
by: Krzysztof Szymanowski, et al.
Published: (2016-09-01)

Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01)

Challenges in Matrix Metalloproteinases Inhibition
by: Helena Laronha, et al.
Published: (2020-05-01)

The possibilities of using the inhibitors of matrix metalloproteinases for keratoplasty
by: K. V. Sirotkina, et al.
Published: (2023-09-01)

The role of matrix metalloproteinases in development of psoriasis and associated comorbidity
by: Khotko A.A.
Published: (2013-09-01)

Association of matrix metalloproteinase-1, 9, 12 and tissue inhibitor of metalloproteinase-1 gene polymorphisms in malay male essential hypertensive subject
by: Tabatabaee, Farizeh Aalam Ghomi
Published: (2015)

Role of Matrix Metalloproteinases in Angiogenesis and Cancer
by: Saray Quintero-Fabián, et al.
Published: (2019-12-01)

Changes in Serum Levels of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Essential Hypertension
by: Krasimir Kostov, et al.
Published: (2022-03-01)

The role of matrix metalloproteinases in early and late gonarthrosis manifestations
by: Ekaterina V. Gladkova
Published: (2020-09-01)

Relationship between Circulating Serpina3g, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 and -2 with Chronic Obstructive Pulmonary Disease Severity
by: Pelin Uysal, et al.
Published: (2019-02-01)

Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer
by: Y. Zhang, et al.

Evaluation of matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in bronchoalveolar lavage of apparently healthy smokers
by: Ali M. Abdella, et al.
Published: (2015-04-01)

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review
by: Joanna Szydełko, et al.
Published: (2019-09-01)

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review
by: Joanna Szydełko, et al.
Published: (2019-09-01)

Enhanced Systemic Response of Matrix Metalloproteinases and Their Regulators in <i>Campylobacter</i> and <i>Salmonella</i> Patients
by: Anna Nilsson, et al.
Published: (2018-12-01)

Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis
by: Yusha Wang, et al.
Published: (2024-08-01)

Association between expression of tissue inhibitors of metalloproteinases-1, matrix metalloproteinase-2, and matrix metalloproteinase-9 genes and axillary lymph nodes metastasis in patients with breast cancer
by: Alireza Abdollahi, et al.
Published: (2019-01-01)

Potential Role of Phytochemicals Against Matrix Metalloproteinase Induced Breast Cancer; An Explanatory Review
by: Yusra Habib Khan, et al.
Published: (2021-01-01)

Activity of genes of matrix metalloproteinases and their inhibitors in the Ligamentum flavum of patients with stenosing processes in spinal canal and dural sac
by: L. V. Rodionova, et al.
Published: (2021-12-01)